Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Knight Therapeutics
AddedFeb 19, 2024
UpdatedJun 28, 2026
Knight Therapeutics

Knight Therapeutics

Public

Knight Therapeutics: A Canadian specialty pharma firm, licensing and offering healthcare products globally.

HQ
Montreal, Quebec, CA
Founded
1995
Overview
Compare
Fundraising
Employees
Website

Knight Therapeutics, founded in Canada, is a specialty pharmaceutical company dedicated to acquiring and licensing pharmaceutical products. Its core mission is to provide innovative healthcare solutions to improve patient outcomes globally. The company focuses on offering a diverse range of healthcare products, targeting various therapeutic areas to meet the needs of the global healthcare industry.

Notable affiliated individuals include key executives and board members with extensive experience in the pharmaceutical sector. Knight Therapeutics has secured investments from reputable financial entities, bolstering its market presence. The company has achieved significant milestones, including successful product launches and strategic partnerships, contributing to its overall impact on global healthcare.

Knight Therapeutics - Similar Companies

NKT Therapeutics logo

NKT Therapeutics

NeuroTherapeutics Pharma logo

NeuroTherapeutics Pharma

Kymera Therapeutics logo

Kymera Therapeutics

kymeratx.com

Karyopharm Therapeutics logo

Karyopharm Therapeutics

karyopharm.com

Kiniksa Pharmaceuticals logo

Kiniksa Pharmaceuticals

kiniksa.com

KinDex Pharmaceuticals logo

KinDex Pharmaceuticals

Manhattan Pharmaceuticals logo

Manhattan Pharmaceuticals

Katana Pharmaceuticals logo

Katana Pharmaceuticals

KPI Therapeutics logo

KPI Therapeutics

Guardian Therapeutics logo

Guardian Therapeutics

Kinaset Therapeutics logo

Kinaset Therapeutics

kinasettx.com

Cambridge Therapeutic Technologies logo

Cambridge Therapeutic Technologies

Athenen Therapeutics logo

Athenen Therapeutics

SphynKx Therapeutics logo

SphynKx Therapeutics

Kirax logo

Kirax

Knight Therapeutics - Quick Facts

Who are Knight Therapeutics' competitors?

Companies similar to Knight Therapeutics include NKT Therapeutics, NeuroTherapeutics Pharma, Kymera Therapeutics and Karyopharm Therapeutics.

When was Knight Therapeutics founded?

Knight Therapeutics was founded in 1995.

Where is Knight Therapeutics' headquarters located?

Knight Therapeutics' headquarters is located in Montreal, Quebec, CA.

When was Knight Therapeutics' last funding round?

Knight Therapeutics' most recent funding round was for $38.5M (USD) in December 2022.

How much has Knight Therapeutics raised to-date?

As of Dec 23, 2022, Knight Therapeutics has raised a total of $636.3M (USD).

How many employees does Knight Therapeutics have?

Knight Therapeutics has 768 employees as of Feb 12, 2024.

Knight Therapeutics - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Licensing
  • Recurring
Customer
  • Enterprise
Main Product
  • Pharmaceuticals
Tags
  • Healthcare
  • Pharma
  • SaaS
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
Show 13 more industry codes
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 620000Health Care and Social Assistance
  • 541000Professional, Scientific, and Technical Services
  • 623000Nursing and Residential Care Facilities
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research